Page last updated: 2024-08-21

quinazolines and Adenoma, Prolactin-Secreting, Pituitary

quinazolines has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ben-Shlomo, A; Cooper, O	1
Bannykh, S; Ben-Shlomo, A; Bonert, V; Carmichael, J; Cook-Wiens, G; Cooper, O; Lim, S; Mamelak, A	1
Araki, T; Cooper, O; Fukuoka, H; Kano, M; Liu, X; Melmed, S; Tone, M; Tone, Y	1
Donangelo, I; Gutman, S; Melmed, S; Ren, SG; Siegel, E; Vlotides, G	1
Bannykh, S; Cooper, O; Fukuoka, H; Melmed, S; Mizutani, J; Ren, SG; Tong, Y	1

Reviews

1 review(s) available for quinazolines and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
Role of tyrosine kinase inhibitors in the treatment of pituitary tumours: from bench to bedside. Current opinion in endocrinology, diabetes, and obesity, 2017, Volume: 24, Issue:4 Topics: Animals; Cell Line, Tumor; ErbB Receptors; Gefitinib; Humans; Lapatinib; Mice; Mice, Transgenic; Pituitary Neoplasms; Prolactinoma; Protein Kinase Inhibitors; Quinazolines; Translational Research, Biomedical	2017

Trials

1 trial(s) available for quinazolines and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors. Endocrine, 2014, Volume: 46, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Lapatinib; Male; Middle Aged; Pilot Projects; Pituitary Neoplasms; Prolactinoma; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Retrospective Studies; Treatment Outcome; Young Adult	2014

Article

Year

Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.

Endocrine, 2014, Volume: 46, Issue:2

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Female; Humans; Lapatinib; Male; Middle Aged; Pilot Projects; Pituitary Neoplasms; Prolactinoma; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Retrospective Studies; Treatment Outcome; Young Adult

2014

Other Studies

3 other study(ies) available for quinazolines and Adenoma, Prolactin-Secreting, Pituitary

Article	Year
ErbB receptor-driven prolactinomas respond to targeted lapatinib treatment in female transgenic mice. Endocrinology, 2015, Volume: 156, Issue:1 Topics: Animals; Antineoplastic Agents; Enhancer Elements, Genetic; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Lapatinib; Mice; Mice, Transgenic; Pituitary Neoplasms; Prolactinoma; Promoter Regions, Genetic; Quinazolines	2015
Rat prolactinoma cell growth regulation by epidermal growth factor receptor ligands. Cancer research, 2008, Aug-01, Volume: 68, Issue:15 Topics: Animals; Antineoplastic Agents; Base Sequence; Blotting, Western; Cell Division; Cell Line, Tumor; Cell Proliferation; DNA Primers; ErbB Receptors; Female; Flow Cytometry; Gefitinib; Gene Expression; Immunoprecipitation; Ligands; Mice; Mice, Nude; Pituitary Neoplasms; Polymerase Chain Reaction; Prolactinoma; Quinazolines; Rats	2008
HER2/ErbB2 receptor signaling in rat and human prolactinoma cells: strategy for targeted prolactinoma therapy. Molecular endocrinology (Baltimore, Md.), 2011, Volume: 25, Issue:1 Topics: Animals; Cell Line, Tumor; Cell Proliferation; Female; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lactotrophs; Lapatinib; Molecular Targeted Therapy; Prolactin; Prolactinoma; Quinazolines; Rats; Receptor, ErbB-2; RNA, Messenger; Signal Transduction	2011